Focused Ultrasound (FUS) is a rapidly maturing medical technology wherein non-ionizing thermal and/or mechanical acoustic energy is deposited in solid tumors under image-guidance. This non-invasive technology may be tuned to synergize with both nascent and established immunotherapies to control primary and disseminated disease.

The University of Virginia (UVA) FUS Cancer Immunotherapy Center was recently formed through investments from the University of Virginia, the Commonwealth of Virginia, and the FUS Foundation. Our mission is to accelerate the discovery and translation of therapeutic FUS immuno-oncology strategies for a number of cancer indications. In so doing, we wish to differentiate UVA as the worldwide leader in translational FUS immuno-oncology research. Our center benefits significantly by being formally affiliated with the UVA Comprehensive Cancer Center.